Bioline RX Ltd Sponsored ADR (BLRX) has released an update.
BioLineRx Ltd. shareholders approved all proposed resolutions at their Annual General Meeting, including the re-election of three Class I directors, the issuance of options to directors, an increase in authorized share capital, and the reappointment of their independent auditors. The annual meeting took place on October 1, 2024, with votes adhering to the Israel Companies Law and the company’s articles of association.
For further insights into BLRX stock, check out TipRanks’ Stock Analysis page.
